Abbott owes $1.7B in Humira patent dispute

June 30th, 2009 09:38 AM - (Reuters) — A U.S. federal jury returned a $1.67 billion verdict against Abbott Laboratories in a patent suit brought by Johnson & Johnson related to arthritis treatments, the drug companies said on Monday.

An Abbott spokesman said the company would appeal the verdict delivered in ...<div class="feedflare">
<a href="http://feeds.feedburner.com/~ff/ChicagoBusinesscomBreakingNews?a=oWLFKyS0gjo:bgtze WMagws:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/ChicagoBusinesscomBreakingNews?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/ChicagoBusinesscomBreakingNews?a=oWLFKyS0gjo:bgtze WMagws:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/ChicagoBusinesscomBreakingNews?i=oWLFKyS0gjo:bgtze WMagws:V_sGLiPBpWU" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/ChicagoBusinesscomBreakingNews?a=oWLFKyS0gjo:bgtze WMagws:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/ChicagoBusinesscomBreakingNews?i=oWLFKyS0gjo:bgtze WMagws:F7zBnMyn0Lo" border="0"></img></a>
</div>

Click here to read article.. (http://feedproxy.google.com/~r/ChicagoBusinesscomBreakingNews/~3/oWLFKyS0gjo/news.pl)